Aglaxiflorin D shows potential in anti-inflammatory applications by inhibiting key pro-inflammatory mediators such as nitric oxide and prostaglandin E2. It has demonstrated activity in cellular models by suppressing the expression of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2), suggesting its possible use in managing inflammatory conditions. Additionally, preliminary studies indicate it may possess antioxidant properties, contributing to cellular protection against oxidative stress. These characteristics make it a candidate for further research in developing natural product-based therapeutics for chronic inflammatory diseases.